Delivery Order SPE2DB22D1202-SPE2DB25FVCR7
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ryanodex 250 mg vials valued at $9,632.64. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a $1,605.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 26, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ryanodex 250 mg vials, with a ceiling value of $3,210.88 and a completion date of October 3, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to AmerisourceBergen's Corporate Office division, with performance occurring at the company's headquarters in Conshohocken, Pennsylvania. The award is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $9,632.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ryanodex 250 mg vials. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ryanodex is a rapid-sequence intubation agent used in emergency...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,816.32 for 250 mg vials of Ryanodex on July 14, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is funded through the Defense Logistics Agency's Medical Supply Chain, reflecting the government's ongoing need for critical pharmaceutical products to...
- The U.S. Defense Medical Supply Chain awarded a $52,979.52 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ryanodex 250mg vials. This firm fixed-price delivery order is set to conclude on August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a $4,816.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ryanodex 250 mg vials, with an ultimate completion date of September 19, 2025. The contract carries no set-aside designation and represents a competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. is for the delivery of 250 mg vials of the drug Ryanodex. The contract has a ceiling value of $2,979.28 and is a firm-fixed price delivery order that runs through October 2024. The contract is not set aside for any specific category of business. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies...
- This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and the pharmaceutical distributor Amerisourcebergen Drug Corp. The $8,937.84 firm fixed-price delivery order is for the supply of RYANODEX 250MG VIAL 1S, a specialty pharmaceutical product. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVCR7Delivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $6,421.76 firm fixed-price delivery order for 250 mg vials of Ryanodex, a muscle relaxant used primarily in anesthesia and critical care settings. This non-competitive delivery order, issued on June 20, 2025, with an ultimate completion date of July 14, 2025, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999 ceiling value and runs through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical and medical supply deliveries through open competition with the DLA Medical Supply Chain, fulfilling requirements across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. This Ryanodex delivery order exemplifies the company's role in supplying specialized pharmaceutical products to support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 6/20/25 |